New York, US – Jan 24, 2019 – Creative Biolabs, a leader in recombinant antibody discovery and manufacturing, recently launched its brand new gram scale antibody production service. Thanks to its abundant experience in protein production, the company is able to generate the most desirable antibodies to fulfill various market demands.
Antibodies have been widely applied to nearly every aspect of life sciences research and modern health care, manifesting a huge potential for the treatment of a host of malicious diseases. Thus, it has become necessary to produce antibodies in large scale, which significantly lowers manufacturing costs and benefits their applications to medical research and health care. The new gram scale antibody production service covers over a dozen of services, of which the prokaryotic antibody production service, the eukaryotic antibody production service as well as the high-throughput antibody production service are the highlights for sure.
“Through years of fast development, our company is capable of supplying a variety of antibodies tailored for our customers’ requirements. Our prokaryotic antibody production service aims to generate superior recombinant biopharmaceuticals, vaccines and polypeptides, including enzymes, antibodies, therapeutic proteins. The service is striking with a success rate of soluble expression up to 95 %. In addition, we offer many kinds of prokaryotic host strains that can achieve standard expression, enhanced expression, toxic expression, and other specific expressions. Importantly, this one-stop service ranges from the beginning design and optimization through the target purification and data analysis report,” a scientist at Creative Biolabs said.
According to the expert, the eukaryotic antibody production service is so comprehensive as to cover almost all the widely used eukaryotic hosts, such as yeasts, filamentous fungi, eukaryotic algae, insect cells, plant cells, mammalian cells, and transgenic animals. So far, the company has produced hundreds of polypeptides, such as enzymes, chemokines, functional peptides and antibodies.
The same scientist from Creative Biolabs added that “The high-throughput antibody production service offers a system of high-throughput gene synthesis and cloning, ensuring a four-week screening and production period starting from the antibody sequencing. In only two weeks after that, the desired antibodies can be expected. We have managed to screen numerous antibodies and produce plenty of high-quality targets, such as antibodies, Fc-fusion proteins and bi-specific antibodies. Notably, thanks to our superior quality control system, the purity of our target antibodies exceeds 95 %. Nowadays, our antibodies have been widely applied to basic research, including demanding drug screening and development. I’m sure we are one of the best antibody manufacturers in the world.”
The introduction of the gram scale antibody production service is certainly of considerable significance to the antibody generation field. With the evolution of medicine and the emergence of more advanced medical technologies, it can be predicted that more diversified antibody production services will be offered to meet the researchers’ requirements.
About Creative Biolabs
Creative Biolabs offers custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb and minibody, etc.), antibody labeling, hybridoma/stable cell line development as well as membrane protein production. Its products range from antibody/peptide libraries, biosimilar cell lines, chimeric antigen receptor products and antibody-drug conjugates to engineered antibodies.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-619-7922Address:45-1 Ramsey Road City: ShirleyState: New YorkCountry: United StatesWebsite: www.creativebiolabs.net/
